Long-term anatomical and functional outcomes after switch to aflibercept therapy for neovascular age-related macular degeneration

被引：0
|
作者：
Chae, Bora [1 ]
Barbazetto, Irene [1 ,2 ]
Gallego-Pinazo, Roberto [2 ,3 ]
Patel, Samir [4 ]
机构：
[1] NYU, Sch Med, Ophthalmol, New York, NY USA
[2] Vitreous Retina Macula Consultants New York, New York, NY USA
[3] Univ & Polytech Hosp La Fe, Ophthalmol, Valencia, Spain
[4] Weill Cornell Med Coll, New York, NY USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4588
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-term Safety of Ranibizumab in Neovascular Age-related Macular Degeneration
    Matonti, Frederic
    Courjaret, Jean Christophe
    Hoffart, Louis
    Amouyal, Franck
    Denis, Daniele
    OPHTHALMOLOGY, 2013, 120 (09) : E68 - E69
  • [32] Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study
    Gale, Richard P.
    Pearce, Ian
    Eter, Nicole
    Ghanchi, Faruque
    Holz, Frank G.
    Schmitz-Valckenberg, Steffen
    Balaskas, Konstantinos
    Burton, Ben J. L.
    Downes, Susan M.
    Eleftheriadis, Haralabos
    George, Sheena
    Gilmour, David
    Hamilton, Robin
    Lotery, Andrew J.
    Patel, Nishal
    Prakash, Priya
    Santiago, Cynthia
    Thomas, Saju
    Varma, Deepali
    Walters, Gavin
    Williams, Michael
    Wolf, Armin
    Zakri, Rosina H.
    Igwe, Franklin
    Ayan, Filis
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2020, 104 (04) : 493 - 499
  • [33] Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Jae Hui Kim
    Jong Woo Kim
    Chul Gu Kim
    Dong Won Lee
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1677 - 1685
  • [34] Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degeneration
    Schneider, Miklos
    Bjerager, Jakob
    Hodzic-Hadzibegovic, Delila
    Klefter, Oliver Niels
    Subhi, Yousif
    Hajari, Javad
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (07) : 2153 - 2162
  • [35] Long-term effect of intravitreal aflibercept treatment on choroidal vascularity index in neovascular age-related macular degeneration
    Alis, Abdulkadir
    Alis, Meryem Guler
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 36
  • [36] Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1677 - 1685
  • [37] LONG-TERM OUTCOMES AFTER THE SURGICAL REMOVAL OF ADVANCED SUBFOVEAL NEOVASCULAR MEMBRANES IN AGE-RELATED MACULAR DEGENERATION
    ORMEROD, LD
    PUKLIN, JE
    FRANK, RN
    OPHTHALMOLOGY, 1994, 101 (07) : 1201 - 1210
  • [38] Long-term outcomes in eyes with early residual fluid in neovascular age-related macular degeneration
    Pedersen, Karina Else
    Wu, Anna K.
    Maatouk, Christopher
    Singh, Rishi P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [39] Long-term Retinal Morphology and Functional Associations in Treated Neovascular Age-Related Macular Degeneration
    Peto, Tunde
    Evans, Rebecca N.
    Reeves, Barnaby C.
    Harding, Simon
    Madhusudhan, Savita
    Lotery, Andrew
    Downes, Susan
    Balaskas, Konstantinos
    Bailey, Clare C.
    Foss, Alexander
    Ghanchi, Faruque
    Yang, Yit
    Phillips, Dawn
    Rogers, Chris A.
    Muldrew, Alyson
    Hamill, Barbra
    Chakravarthy, Usha
    OPHTHALMOLOGY RETINA, 2022, 6 (08): : 664 - 675
  • [40] Aflibercept for Intravitreal Injection In Neovascular Age-Related Macular Degeneration
    Frampton, James E.
    DRUGS & AGING, 2012, 29 (10) : 839 - 846
12345